Windtree Therapeutics (WINT) announced the appointment of Leanne Kelly to its board of directors. Kelly has served as GRI Bio’s Chief Financial Officer since April 2023.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WINT:
- Windtree lauches new corporate strategy to become revenue generating biotech
- Windtree Therapeutics announces presentation highlighting istaroxime
- Windtree Therapeutics announces new istaroxime patent filing
- Windtree Therapeutics announces partnership with New Growth Advisors
- Windtree Therapeutics Reports Q3 2024 Financial Results